| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |